This Article Full Text Full Text (PDF) All Versions of this Article: 2004-0269OCv1 32/5/428    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zimmermann, N. Articles by Rothenberg, M. E. Search for Related Content PubMed PubMed Citation Articles by Zimmermann, N. Articles by Rothenberg, M. E.

Expression and Regulation of Small Proline-Rich Protein 2 in Allergic Inflammation

Divisions of Allergy and Immunology, Pathology, and Immunobiology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine; Division of Immunology, Department of Internal Medicine, University of Cincinnati College of Medicine; and the Veteran's Administration Medical Center, Cincinnati, Ohio

Correspondence and requests for reprints should be addressed to Marc Rothenberg, M.D., Ph.D., Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229. E-mail: Rothenberg{at}cchmc.org

Asthma is a complex inflammatory pulmonary disorder that is on the rise despite intense ongoing research. We aimed to elucidate novel pathways involved in the pathogenesis of asthma. Employing asthma models induced by different allergens (ovalbumin and Aspergillus fumigatus), we uncovered the involvement of two members of the small proline-rich protein (SPRR) family, SPRR2a and SPRR2b, known to be involved in epithelial differentiation but not allergic disease. In situ hybridization revealed induction of SPRR2 signal in a subset of bronchial epithelial cells and mononuclear cells associated with inflammation after allergen challenge. Allergen-induced SPRR2 mRNA accumulation in the lung occurred in a time-dependent manner, with peak expression 10–96 h after a second ovalbumin challenge. Transgenic overexpression of interleukin (IL)-13 in the lungs resulted in a marked increase of SPRR2 expression, and allergen-induced SPRR2 expression was significantly decreased in IL-13–deficient mice. Studies in gene-targeted mice revealed that allergen-induced SPRR2 was dependent upon STAT6. Finally, we aimed to determine if the induction of SPRR2 by allergen was tissue specific. Notably, SPRR2 was markedly increased in the small intestine after induction of allergic gastrointestinal inflammation. Thus, SPRR2 is an allergen- and IL-13–induced gene in experimental allergic responses that may be involved in disease pathophysiology.

Key Words: asthma • allergy • small proline-rich protein

This article has been cited by other articles:

				R. Tachdjian, C. Mathias, S. Al Khatib, P. J. Bryce, H. S. Kim, F. Blaeser, B. D. O'Connor, D. Rzymkiewicz, A. Chen, M. J. Holtzman, et al. Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma J. Exp. Med., September 28, 2009; 206(10): 2191 - 2204. [Abstract] [Full Text] [PDF]

				G. Tolgyesi, V. Molnar, A. F. Semsei, P. Kiszel, I. Ungvari, P. Pocza, Z. Wiener, Z. I. Komlosi, L. Kunos, G. Galffy, et al. Gene expression profiling of experimental asthma reveals a possible role of paraoxonase-1 in the disease Int. Immunol., August 1, 2009; 21(8): 967 - 975. [Abstract] [Full Text] [PDF]

				L. Zheng, Z. Zhou, L. Lin, S. Alber, S. Watkins, N. Kaminski, A. M. K. Choi, and D. Morse Carbon Monoxide Modulates {alpha}-Smooth Muscle Actin and Small Proline Rich-1a Expression in Fibrosis Am. J. Respir. Cell Mol. Biol., July 1, 2009; 41(1): 85 - 92. [Abstract] [Full Text] [PDF]

				N. Novershtern, Z. Itzhaki, O. Manor, N. Friedman, and N. Kaminski A Functional and Regulatory Map of Asthma Am. J. Respir. Cell Mol. Biol., March 1, 2008; 38(3): 324 - 336. [Abstract] [Full Text] [PDF]

				S. Li, K. Nikulina, J. DeVoss, A. J. Wu, E. C. Strauss, M. S. Anderson, and N. A. McNamara Small Proline-Rich Protein 1B (SPRR1B) Is a Biomarker for Squamous Metaplasia in Dry Eye Disease Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 34 - 41. [Abstract] [Full Text] [PDF]

				J. J. Reece, M. C. Siracusa, and A. L. Scott Innate Immune Responses to Lung-Stage Helminth Infection Induce Alternatively Activated Alveolar Macrophages Infect. Immun., September 1, 2006; 74(9): 4970 - 4981. [Abstract] [Full Text] [PDF]

				A. L. Greene, M. S. Rutherford, R. R. Regal, G. H. Flickinger, J. A. Hendrickson, C. Giulivi, M. E. Mohrman, D. G. Fraser, and J. F. Regal Arginase Activity Differs with Allergen in the Effector Phase of Ovalbumin- versus Trimellitic Anhydride-Induced Asthma Toxicol. Sci., December 1, 2005; 88(2): 420 - 433. [Abstract] [Full Text] [PDF]

				S H Murch Probiotics as mainstream allergy therapy? Arch. Dis. Child., September 1, 2005; 90(9): 881 - 882. [Full Text] [PDF]